Pigment Processor

This Korean-made treatment is conceived as a “smart serum,” combining pigment-targeting actives with barrier-supportive ingredients to visibly improve areas of uneven tone and texture while preserving the complexion’s natural radiance. At the center of the formula is 3% cetyl tranexamate mesylate; a next-generation derivative of tranexamic acid selected to target the appearance of dark spots and redness. It works alongside 1% kojic acid dipalmitate to encourage a more uniform complexion, 4% niacinamide to support the barrier and refine the appearance of pores, and amber algae to help brighten and enhance your natural skin tone. The lightweight treatment is designed for both morning and evening use, making it a streamlined approach to addressing discoloration.   Dermatologist tested, fragrance-free, vegan, cruelty-free, and formulated for all skin tones. Inside the Formula: Cetyl Tranexamate Mesylate 3%: A next-generation form of tranexamic acid developed for enhanced bioavailability that helps target the appearance of discoloration and redness for a more even complexion Niacinamide 4%: A multitasking form of vitamin B3 that helps strengthen the skin barrier, soothe the complexion, and refine the visible appearance of pores Kojic Acid Dipalmitate 1%: A more stable, lipid-soluble derivative of kojic acid used to help brighten the complexion and improve the appearance of uneven tone Amber Algae 0.1%: A marine-derived antioxidant selected to support luminosity while helping preserve the skin’s natural tone Ascorbyl Glucoside + Vitamin E: Antioxidant support to defend against environmental stress Bisabolol: A soothing and comforting botanical-derived ingredient that helps temper visible signs of irritation Clinicals: In an eight-week clinical study*, 50% of participants demonstrated improvement in discoloration, 55% in skin texture, and 82% in the appearance of pores.   *The formula was evaluated as part of Reframe’s ongoing clinical research conducted in partnership with Howard University’s Department of Dermatology, with participants spanning Fitzpatrick skin types I–VI.